US5187193A
(en)
*
|
1988-09-12 |
1993-02-16 |
University Of Rochester |
Method for stimulating transplanted bone marrow cells
|
WO1991005571A1
(en)
*
|
1989-10-10 |
1991-05-02 |
University Of Rochester |
Method for producing bone marrow growth cell factors
|
CA2113990A1
(en)
*
|
1991-07-26 |
1993-02-18 |
Frederick L. Moolten |
Cancer therapy utilizing malignant cells
|
US5240914A
(en)
*
|
1992-02-03 |
1993-08-31 |
Adolph Schwimmer |
Method and compositions for inhibiting tumor cell metabolism
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
US7135584B2
(en)
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5962437A
(en)
*
|
1994-08-29 |
1999-10-05 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5616575A
(en)
*
|
1995-12-04 |
1997-04-01 |
Regents Of The University Of Minnesota |
Bioactive tricyclic ibogaine analogs
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
US5922761A
(en)
*
|
1996-09-06 |
1999-07-13 |
Medinox, Inc. |
Methods for in vivo reduction of iron levels and compositions useful therefor
|
TR199900636T2
(xx)
*
|
1996-09-23 |
1999-10-21 |
Rutgers, The State University Of New Jersey |
Anti-t�m�r ajanlar� olarak ikameli/katk�l� heterosayk�llar.
|
US5916903A
(en)
*
|
1997-02-28 |
1999-06-29 |
Synapse Pahrmaceuticals International, Inc. |
Method for reducing the effects of antineoplastic disease treatment
|
US5866558A
(en)
*
|
1997-05-08 |
1999-02-02 |
Regents Of The University Of Minnesota |
6-alkynyl steroids
|
US6468519B1
(en)
|
1997-09-10 |
2002-10-22 |
Rutgers, The State University Of New Jersey |
Polyanhydrides with biologically active degradation products
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
US6140328A
(en)
*
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
WO1999033838A1
(en)
*
|
1997-12-29 |
1999-07-08 |
Research Corporation Technologies, Inc. |
2-β-SUBSTITUTED-6-ALKYLIDENE PENICILLANIC ACID DERIVATIVES AS β-LACTAMASE INHIBITORS
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
US6051603A
(en)
*
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
US6063801A
(en)
|
1998-02-12 |
2000-05-16 |
Rutgers, The State University Of New Jersey |
Heterocyclic topoisomerase poisons
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
US6355678B1
(en)
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
US6232297B1
(en)
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
US6166003A
(en)
*
|
1999-02-17 |
2000-12-26 |
Lkt Laboratories, Inc. |
Heterocyclic compounds for cancer chemoprevention
|
US6638518B1
(en)
|
1999-02-22 |
2003-10-28 |
University Of Iowa Research Foundation |
Method for inhibiting inflammatory responses
|
US6080747A
(en)
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
PL350651A1
(en)
|
1999-03-09 |
2003-01-27 |
Upjohn Co |
4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
US6258820B1
(en)
*
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
US7064114B2
(en)
*
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
AU5630800A
(en)
*
|
1999-06-22 |
2001-01-09 |
Arno F Spatola |
Antimicrobial agents
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
US7151100B1
(en)
*
|
1999-07-23 |
2006-12-19 |
The Regents Of The University Of California |
Indole compounds useful for the treatment of cancer
|
US6852685B1
(en)
|
1999-08-17 |
2005-02-08 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
|
US6903068B1
(en)
|
1999-08-17 |
2005-06-07 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
|
AU7061700A
(en)
|
1999-08-17 |
2001-03-13 |
University Of Texas System, The |
Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
|
US7119064B2
(en)
*
|
1999-08-17 |
2006-10-10 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
US6649654B1
(en)
*
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
US20040038948A1
(en)
|
1999-12-07 |
2004-02-26 |
Uhrich Kathryn E. |
Therapeutic compositions and methods
|
ES2252187T3
(es)
*
|
2000-01-20 |
2006-05-16 |
Regents Of The University Of Minnesota |
Peptidos con actividad antibacteriana.
|
BR0108803A
(pt)
|
2000-03-21 |
2002-11-05 |
Upjohn Co |
4-oxo-1,4-diidro[1,8]naftiridina-3-carboxamidas como agentes antivirais
|
EP1265896A1
(en)
|
2000-03-21 |
2002-12-18 |
PHARMACIA & UPJOHN COMPANY |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
CA2399741A1
(en)
|
2000-03-21 |
2001-11-01 |
Scott D. Larsen |
4-hydroxycinnoline-3-carboxyamides as antiviral agents
|
US6682892B2
(en)
*
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
AU2001294959A1
(en)
|
2000-09-29 |
2002-04-08 |
Robert M. Carlson |
Triterpenes having antibacterial activity
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
US6642217B2
(en)
|
2000-09-29 |
2003-11-04 |
Naturtek, Llc |
Triterpenes having human antifungal and antiyeast activity
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
WO2002060936A2
(en)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US6703524B2
(en)
*
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
US6960738B2
(en)
*
|
2001-05-29 |
2005-11-01 |
Koninklijke Philips Electronics N.V. |
Metal-ceramic bond
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
ATE339424T1
(de)
*
|
2001-07-24 |
2006-10-15 |
Univ Southern Methodist |
3-substituierte 7-alkylidene-3-cephem-4- carbonsäuren als beta-lactamase inhibitoren
|
US6753414B2
(en)
*
|
2001-08-07 |
2004-06-22 |
University Of Iowa Research Foundation, Inc. |
Process for preparing saponin compounds
|
DE60206636T2
(de)
|
2001-08-08 |
2006-06-22 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
THERAPEUTISCHE 1H-PYRIDO[4,3-b]INDOLE
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
WO2003020728A1
(en)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
|
JP4714413B2
(ja)
*
|
2001-08-31 |
2011-06-29 |
トムソン ライセンシング |
オーディオビジュアルストリームのためのシーケンスカウンタ
|
US6887868B2
(en)
*
|
2001-09-21 |
2005-05-03 |
Pharmacia & Upjohn Company |
Therapeutic 5-HT ligand compounds
|
EP1430017A2
(en)
|
2001-09-26 |
2004-06-23 |
Theravance, Inc. |
Substituted phenol compounds useful for anesthesia and sedation
|
AU2002362443B2
(en)
*
|
2001-10-01 |
2008-05-15 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
WO2003031587A2
(en)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
DE60238435D1
(de)
*
|
2001-10-26 |
2011-01-05 |
Scripps Research Inst |
Gezielte thrombose durch gewebefaktor polypeptiden
|
MXPA04004606A
(es)
|
2001-11-14 |
2004-09-10 |
Univ Rutgers |
Venenos de topoisomerasa solubilizados.
|
WO2003041653A2
(en)
|
2001-11-14 |
2003-05-22 |
Rutgers, The State University |
Cytotoxic agents
|
WO2003046034A2
(en)
|
2001-11-23 |
2003-06-05 |
Rutgers, The State University |
Improved synthesis of polyanhyrides
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
JP2005530685A
(ja)
*
|
2002-01-25 |
2005-10-13 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
選択的鎮痛剤
|
WO2003066067A2
(en)
*
|
2002-02-04 |
2003-08-14 |
Alfama - Investigaçao E Desenvolvimento De Produtos Farmaceuticos Lda. |
Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
CN1646068A
(zh)
|
2002-02-07 |
2005-07-27 |
拉特格斯,新泽西州立大学 |
治疗用的聚酯和聚酰胺
|
WO2003072053A2
(en)
|
2002-02-22 |
2003-09-04 |
The Curators Of The University Of Missouri |
Compounds for treatment of copper overload
|
US20050032713A1
(en)
*
|
2002-03-27 |
2005-02-10 |
Wurtman Richard J. |
Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
|
US7022691B2
(en)
*
|
2002-04-04 |
2006-04-04 |
John D. Buynak |
Inhibitors of serine and metallo-β-lactamases
|
KR101036058B1
(ko)
*
|
2002-04-25 |
2011-05-19 |
더 스크립스 리서치 인스티튜트 |
폐질환 증상의 치료 및 예방
|
US7026472B2
(en)
*
|
2002-05-06 |
2006-04-11 |
University Of South Florida |
Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
US20060093595A1
(en)
*
|
2002-07-05 |
2006-05-04 |
Mahesh Jayachandra |
Methods, compositions and kits for treating damage to excitable tissue
|
WO2004014918A1
(en)
*
|
2002-08-09 |
2004-02-19 |
Rutgers, The State University |
Nitro and amino substituted topoisomerase agents
|
AU2003260821A1
(en)
*
|
2002-09-11 |
2004-04-30 |
Warner-Lambert Company Llc |
Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
|
AU2003295336A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Dennis A. Carson |
Use of etodoclac to treat hyperplasia
|
CA2501939C
(en)
|
2002-10-10 |
2013-10-08 |
Cornell Research Foundation, Inc. |
Novel immunogenic proteins of leptospira
|
EP1552025A4
(en)
*
|
2002-10-18 |
2006-12-13 |
Cylene Pharmaceuticals Inc |
METHODS FOR IDENTIFYING TARGETED ANTIVIRAL MOLECULES TO QUADRUPLEX STRUCTURES
|
WO2004037851A2
(en)
*
|
2002-10-22 |
2004-05-06 |
Board Of Regents The University Of Texas System |
Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis
|
CA2509834A1
(en)
*
|
2002-10-28 |
2004-05-13 |
Paraquest, Inc. |
Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia
|
EP3299393A1
(en)
|
2002-11-08 |
2018-03-28 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
EP1558647B1
(en)
|
2002-11-08 |
2015-06-10 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
WO2004047800A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
US8119854B2
(en)
*
|
2002-12-10 |
2012-02-21 |
Pietro P. Sanna |
Role of proteoglycans in drug dependence
|
CA2509662A1
(en)
*
|
2002-12-10 |
2004-06-24 |
The Scripps Research Institute |
A method for treatment of drug addiction and for screening of pharmaceutical agents therefor
|
WO2004062583A2
(en)
*
|
2003-01-07 |
2004-07-29 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
RU2357974C2
(ru)
|
2003-01-10 |
2009-06-10 |
Аблинкс Н.В. |
Терапевтические полипептиды, их гомологи, их фрагменты и их применение для модуляции агрегации, опосредованной тромбоцитами
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
WO2004087673A2
(en)
|
2003-03-28 |
2004-10-14 |
Sloan-Kettering Institute For Cancer Research |
Migrastatin analogs and uses thereof
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
KR100944600B1
(ko)
*
|
2003-04-07 |
2010-02-25 |
사일린 파마슈티칼스, 인크 |
치환된 퀴노벤족사진 유사체
|
WO2004091627A2
(en)
*
|
2003-04-07 |
2004-10-28 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
|
US20040248880A1
(en)
*
|
2003-04-25 |
2004-12-09 |
Jacobsen Eric Jon |
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
|
AU2004248138B2
(en)
*
|
2003-05-29 |
2009-09-03 |
The Scripps Research Institute |
Targeted delivery to legumain-expressing cells
|
WO2005009434A2
(en)
|
2003-06-25 |
2005-02-03 |
The Burnham Institute |
Compounds and methods for inducing apoptosis in cancer cells
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
PL1658291T3
(pl)
|
2003-08-25 |
2014-03-31 |
Dogwood Pharmaceuticals Inc |
Podstawione 8-heteroaryloksantyny
|
PL2520654T3
(pl)
|
2003-08-26 |
2017-08-31 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
WO2005042699A2
(en)
*
|
2003-10-17 |
2005-05-12 |
Regents Of The University Of Minnesota |
Modified polypeptides with therapeutic activity and methods of use
|
ATE485307T1
(de)
|
2003-11-07 |
2010-11-15 |
Ablynx Nv |
Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
|
CA2549160A1
(en)
*
|
2003-12-04 |
2005-06-23 |
The Scripps Research Institute |
Treatment and preventions of asthma
|
EP2299266A1
(en)
*
|
2003-12-19 |
2011-03-23 |
The Regents of the University of California |
Methods and materials for assessing prostate cancer therapies
|
EP2384744A1
(en)
|
2004-01-14 |
2011-11-09 |
Gilead Sciences, Inc. |
Lipid-based dispersions useful for drug delivery
|
WO2005072766A2
(en)
*
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides that bind to hsp90 proteins
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
AU2005232526B2
(en)
*
|
2004-02-24 |
2011-06-23 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
PL2574341T3
(pl)
|
2004-03-29 |
2017-09-29 |
University Of South Florida |
Efektywne leczenie guzów i raka fosforanem tricyrybiny
|
JP5149001B2
(ja)
*
|
2004-05-25 |
2013-02-20 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
癌の処置におけるマイグラスタチンアナログ
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
NZ585697A
(en)
*
|
2004-08-02 |
2011-12-22 |
Univ Virginia Patent Found |
2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
|
WO2006023272A1
(en)
*
|
2004-08-02 |
2006-03-02 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having a2a agonist activity
|
EP1793832B1
(en)
*
|
2004-08-25 |
2014-07-23 |
University of Iowa Research |
Geranylgeranyl pyrophosphate synthase inhibitors
|
EP1796634A4
(en)
*
|
2004-09-13 |
2012-07-18 |
Gilead Sciences Inc |
IRON ADMINISTRATION TO AN ANIMAL
|
WO2006034478A2
(en)
*
|
2004-09-23 |
2006-03-30 |
Sloan-Kettering Institute For Cancer Research |
Isomigrastatin analogs in the treatment of cancer
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
WO2006040153A2
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
US7605241B2
(en)
*
|
2005-01-10 |
2009-10-20 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90Rsk
|
US7691364B2
(en)
*
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
PT2444085E
(pt)
|
2005-05-13 |
2015-06-11 |
Univ California |
Compostos de diaril-hidantoínas como antagonistas do recetor androgénio para tratamento de cancro
|
PL1888641T3
(pl)
|
2005-05-18 |
2012-05-31 |
Ablynx Nv |
Białka wiążące albuminę surowicy
|
NZ563392A
(en)
|
2005-05-20 |
2009-12-24 |
Ablynx Nv |
Improved Nanobodies(TM) for the treatment of aggregation-mediated disorders
|
US20070025910A1
(en)
|
2005-07-29 |
2007-02-01 |
Norenberg Jeffrey P |
Anticancer therapy
|
EP1909783B1
(en)
*
|
2005-08-03 |
2011-10-12 |
The Regents of the University of California |
Illudin analogs useful as anticancer agents
|
ES2577514T3
(es)
|
2005-08-22 |
2016-07-15 |
The Regents Of The University Of California |
Antagonistas de TLR
|
JP5259408B2
(ja)
|
2005-08-29 |
2013-08-07 |
ユニバーシティ オブ バージニア パテント ファンデーション |
リソフィリン類縁体とその使用方法
|
US8871764B2
(en)
|
2005-08-29 |
2014-10-28 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
WO2008108842A1
(en)
|
2007-02-28 |
2008-09-12 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
WO2007053794A2
(en)
|
2005-10-21 |
2007-05-10 |
Bezwada Biomedical Llc |
Functionalized phenolic compounds and absorbable therefrom
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
CN101374856A
(zh)
*
|
2005-11-29 |
2009-02-25 |
斯克里普斯研究学院 |
抑制肿瘤细胞浸润、转移和血管生成
|
US8007526B2
(en)
|
2005-12-01 |
2011-08-30 |
Bezwada Biomedical, Llc |
Difunctionalized aromatic compounds and polymers therefrom
|
WO2007078615A2
(en)
*
|
2005-12-15 |
2007-07-12 |
Cavit Sciences, Inc |
Methods and compositions for treatment of cancer
|
WO2007073226A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release co
|
US20070244057A1
(en)
*
|
2006-01-20 |
2007-10-18 |
Henry Paulson |
Suppressing polyglutamine aggregation and toxicity
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
US7615649B2
(en)
*
|
2006-01-26 |
2009-11-10 |
Iowa State University Research Foundation, Inc, |
Synthesis of polycyclic procyanidins
|
WO2007120972A2
(en)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
CA2643546A1
(en)
*
|
2006-02-21 |
2007-08-30 |
The Ohio State University Research Foundation |
Anticancer agents
|
US9670244B2
(en)
|
2006-02-27 |
2017-06-06 |
The Regents Of The University Of California |
Oxysterol compounds and the hedgehog pathway
|
NZ595571A
(en)
|
2006-02-28 |
2013-04-26 |
Helicon Therapeutics Inc |
Pyrazole compounds and uses thereof
|
US8093274B2
(en)
*
|
2006-03-22 |
2012-01-10 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
EP2656842B1
(en)
|
2006-03-27 |
2016-08-10 |
The Regents of The University of California |
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
|
EP3020706A1
(en)
|
2006-03-29 |
2016-05-18 |
The Regents Of The University Of California |
Diarylthiohydantoin compounds useful for the treatment of a hyperproliferative disorder
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
EP2029597A4
(en)
|
2006-05-31 |
2011-11-23 |
Univ California |
purine analogs
|
US8318812B2
(en)
*
|
2006-06-02 |
2012-11-27 |
The Ohio State University Research Foundation |
Therapeutic agents for the treatment of lymphoid malignancies
|
WO2007146813A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs as cell proliferation inhibitors
|
US20100305136A1
(en)
*
|
2006-06-08 |
2010-12-02 |
Johnny Yasuo Nagasawa |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
WO2007149277A2
(en)
|
2006-06-16 |
2007-12-27 |
Pgx Health, Llc |
Substituted 8-[6-amino-3-pyridyl]xanthines
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
WO2008034019A2
(en)
|
2006-09-13 |
2008-03-20 |
Polymerix Corporation |
Active agents and their oligomers and polymers
|
WO2008036244A1
(en)
*
|
2006-09-18 |
2008-03-27 |
The Burham Institute For Medical Research |
Use of cyclosporin a to sensitize resistant cancer cells to death receptor ligands
|
US8022246B2
(en)
*
|
2006-10-10 |
2011-09-20 |
The Burnham Institute For Medical Research |
Neuroprotective compositions and methods
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
JP2010511034A
(ja)
*
|
2006-11-29 |
2010-04-08 |
ファイザー・プロダクツ・インク |
第Xa因子阻害剤としての(R)−5−メチル−4,5−ジヒドロ−ピラゾール−1,5−ジカルボン酸1−[(4−クロロ−フェニル)−アミド]5−{[2−フルオロ−4−(2−オキソ−2H−ピリジン−1−イル)−フェニル]−アミド}
|
EP2115004A2
(en)
|
2006-12-19 |
2009-11-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
EP2514767A1
(en)
|
2006-12-19 |
2012-10-24 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
EP2111385B1
(en)
|
2007-02-06 |
2014-11-12 |
University Of Louisville Research Foundation, Inc. |
Substituted alkine derivatives as anti-cancer agents
|
PL2510946T3
(pl)
|
2007-02-07 |
2015-12-31 |
Univ California |
Koniugaty syntetycznych agonistów tlr i ich zastosowania
|
US20100143270A1
(en)
*
|
2007-02-21 |
2010-06-10 |
University Of Louisville Research Foubdation |
Therapeutic cotinine compositions
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
AU2008274956B2
(en)
|
2007-07-12 |
2014-08-21 |
University Of South Florida |
Inhibitors of Akt/PKB with anti-tumor activity
|
WO2009018551A2
(en)
|
2007-08-02 |
2009-02-05 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
WO2009025797A1
(en)
*
|
2007-08-16 |
2009-02-26 |
Burnham Institute For Medical Research |
Compositions and methods for treating symptoms of aging
|
MX2010002258A
(es)
|
2007-08-27 |
2010-04-22 |
Helicon Therapeutics Inc |
Compuestos terapeuticos de isoxazol.
|
US8217134B2
(en)
*
|
2007-08-30 |
2012-07-10 |
Bezwada Biomedical, Llc |
Controlled release of biologically active compounds
|
US8048980B2
(en)
|
2007-09-17 |
2011-11-01 |
Bezwada Biomedical, Llc |
Hydrolysable linkers and cross-linkers for absorbable polymers
|
KR101601332B1
(ko)
*
|
2007-10-05 |
2016-03-08 |
센화 바이오사이언시즈 인코포레이티드 |
퀴놀론 유사체 및 이와 관련된 방법
|
WO2009052443A1
(en)
|
2007-10-19 |
2009-04-23 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
CA2966280A1
(en)
|
2007-10-26 |
2009-04-30 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
WO2009059030A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Burnham Institute For Medical Research |
Pyrazole derivatives as kinase inhibitors
|
EP2231164A1
(en)
|
2007-12-03 |
2010-09-29 |
The Regents of the University of California |
Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
EP2259788A4
(en)
*
|
2008-02-07 |
2011-03-16 |
Univ California |
TREATMENT OF BLADDER DISEASES WITH A TLR7 ACTIVATOR
|
WO2009108716A2
(en)
|
2008-02-27 |
2009-09-03 |
University Of Louisville Research Foundation |
Synthetic peptides
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
WO2009114921A1
(en)
*
|
2008-03-17 |
2009-09-24 |
Dmitrienko Gary I |
INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
CN102056945A
(zh)
|
2008-04-07 |
2011-05-11 |
埃博灵克斯股份有限公司 |
针对Notch途径的单可变结构域
|
CN102099378B
(zh)
|
2008-05-16 |
2016-01-20 |
埃博灵克斯股份有限公司 |
针对CXCR4和其他GPCRs的氨基酸序列以及包含所述氨基酸序列的多肽
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
EP2299809B1
(en)
|
2008-06-17 |
2018-10-17 |
Ben Gurion University Of The Negev R&D Authority |
Substituted cyclohexylidene-ethylidene-octahydro-indene compounds
|
US8673910B2
(en)
*
|
2008-06-30 |
2014-03-18 |
H. Lee Moffitt Cancer Center And Research Institute |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
WO2010014054A1
(en)
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
KR20110068993A
(ko)
*
|
2008-08-05 |
2011-06-22 |
유니버시티 오브 사우스 플로리다 |
인지장애의 치료방법
|
WO2010017550A2
(en)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for supression of tumorigenesis
|
US9801865B2
(en)
*
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
US8124654B2
(en)
*
|
2008-11-11 |
2012-02-28 |
Immune Modulation, Inc. |
Derivatives of hypoestoxide and related compounds
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
US8729088B2
(en)
|
2009-02-11 |
2014-05-20 |
The Regents Of The University Of California |
Toll-like receptor modulators and treatment of diseases
|
EP2403856B1
(en)
|
2009-03-06 |
2012-12-19 |
Rutgers, The State University of New Jersey |
Methylenedioxybenzo [i]phenanthridine derivatives used to treat cancer
|
JP2012521365A
(ja)
|
2009-03-20 |
2012-09-13 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
抗結核剤としてのプレニル化ビスホスホネート
|
CA2758191C
(en)
|
2009-04-10 |
2015-06-30 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
CN102395268A
(zh)
|
2009-04-15 |
2012-03-28 |
桑福德-伯纳姆医学研究院 |
基于萘的抗凋亡蛋白抑制剂
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
US8906965B2
(en)
|
2009-05-11 |
2014-12-09 |
The University Of Tennessee Research Foundation |
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
|
ES2787599T3
(es)
|
2009-05-13 |
2020-10-16 |
Univ Virginia Patent Foundation |
Inhibidores de leucemia inv(16)
|
JP2012532140A
(ja)
|
2009-06-30 |
2012-12-13 |
フォレスト・ラボラトリーズ・ホールディングス・リミテッド |
A2ar作動薬としてのアルコキシ−カルボニル−アミノ−アルキニル−アデノシン化合物及びその誘導体
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
CN102470129A
(zh)
|
2009-07-09 |
2012-05-23 |
Cbt发展有限公司 |
作为药物使用的组合制剂
|
MX2012001420A
(es)
|
2009-07-31 |
2012-03-26 |
Biocryst Pharm Inc |
Derivados de pirrolo[1,2-b]piridazina como inhibidores de cinasa janus.
|
WO2011019995A2
(en)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthesis and identification of novel rsk-specific inhibitors
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
WO2011028638A1
(en)
|
2009-09-04 |
2011-03-10 |
Schering Corporation |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
|
CN102548945A
(zh)
*
|
2009-10-08 |
2012-07-04 |
桑福德-伯纳姆医学研究院 |
作为抗癌剂的阿朴棉子酚酮衍生物
|
US8796300B2
(en)
|
2009-11-05 |
2014-08-05 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
KR20120092175A
(ko)
|
2009-12-04 |
2012-08-20 |
죤 이. 그랜트 |
카테콜-0-메틸-트랜스퍼라제 저해제를 사용한 충동 제어 장애의 치료
|
RU2012130929A
(ru)
|
2009-12-23 |
2014-01-27 |
Байокрист Фармасьютикалз, Инк. |
Гетероциклические соединения в качестве ингибиторов янус-киназы
|
CN102892755A
(zh)
|
2009-12-23 |
2013-01-23 |
韦恩州立大学 |
治疗性化合物
|
PT3124481T
(pt)
|
2010-02-16 |
2018-06-18 |
Aragon Pharmaceuticals Inc |
Moduladores do receptor de androgénios e suas utilizações
|
US20120329770A1
(en)
|
2010-02-26 |
2012-12-27 |
Gary Igor Dmitrienko |
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
|
CA2794958A1
(en)
|
2010-03-29 |
2011-10-06 |
Surmodics, Inc. |
Injectable drug delivery formulation
|
JP2013523777A
(ja)
|
2010-04-02 |
2013-06-17 |
ティーエスアールエル インコーポレイテッド |
ノイラミニダーゼ阻害剤
|
US20130130965A1
(en)
|
2010-04-08 |
2013-05-23 |
University Of Virginia Patent Foundation |
Method to detect and treat infectious or inflammatory diarrhea based on reg1
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
KR20130083389A
(ko)
|
2010-05-28 |
2013-07-22 |
바이오크리스트파마슈티컬즈,인코포레이티드 |
야누스 키나아제 억제제로서 헤테로사이클릭 화합물
|
US8933096B2
(en)
|
2010-06-09 |
2015-01-13 |
Rugers, The State University of New Jersey |
Antimicrobial agents
|
CA2803890A1
(en)
|
2010-06-25 |
2011-12-29 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US8741317B2
(en)
|
2010-08-19 |
2014-06-03 |
Rutgers, The State University Of New Jersey |
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
US20120083473A1
(en)
|
2010-09-21 |
2012-04-05 |
Johanna Holldack |
Treatment of conditions by toll-like receptor modulators
|
KR20140014077A
(ko)
|
2010-10-25 |
2014-02-05 |
리전츠 오브 더 유니버스티 오브 미네소타 |
교모세포종의 치료를 위한 치료 조성물
|
WO2012058665A1
(en)
|
2010-10-29 |
2012-05-03 |
University Of Connecticut |
Compositions and methods for modulation and detection of immune and inflammatory responses
|
EP2635274B1
(en)
|
2010-11-01 |
2017-12-06 |
The Ohio State University Research Foundation |
Anti-staphylococcal celecoxib derivatives
|
WO2012065051A1
(en)
|
2010-11-12 |
2012-05-18 |
Enzon Pharmaceuticals, Inc. |
Compositions and methods for treating androgen receptor dependent disorders including cancers
|
WO2012074960A2
(en)
|
2010-11-29 |
2012-06-07 |
The Ohio State University Research Foundation |
Fty720-derived anticancer agents
|
US8546397B2
(en)
|
2010-12-20 |
2013-10-01 |
The Ohio State University Research Foundation |
DNA methylation inhibitors
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
EP3150590B1
(en)
|
2011-02-07 |
2019-10-16 |
Biogen MA Inc. |
S1p modulating agents
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
WO2012122219A2
(en)
|
2011-03-07 |
2012-09-13 |
University Of Louisville Research Foundation |
Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
|
US9616064B2
(en)
|
2011-03-30 |
2017-04-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Rho kinase inhibitors and methods of use
|
US10059746B2
(en)
|
2011-04-04 |
2018-08-28 |
University Of Iowa Research Foundation |
Methods of improving vaccine immunogenicity
|
WO2012139015A1
(en)
|
2011-04-06 |
2012-10-11 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
EP2699242B1
(en)
|
2011-04-19 |
2017-11-01 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
WO2012177770A1
(en)
|
2011-06-20 |
2012-12-27 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial rna polymerase
|
US9133230B2
(en)
|
2011-06-21 |
2015-09-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
|
WO2013009647A1
(en)
|
2011-07-08 |
2013-01-17 |
Regents Of The University Of Minnesota |
Glutathione analogs and uses thereof
|
EP2734235B1
(en)
|
2011-07-21 |
2017-03-22 |
Alfama, Inc. |
Ruthenium carbon monoxide releasing molecules and uses thereof
|
EP2734519B1
(en)
|
2011-07-22 |
2016-05-04 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
EA028452B1
(ru)
|
2011-07-29 |
2017-11-30 |
Медивейшн Простейт Терапьютикс, Инк. |
Лечение рака молочной железы
|
US20150017091A1
(en)
|
2011-08-18 |
2015-01-15 |
Cornell University |
Detection and treatment of metastatic disease
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
WO2013033345A1
(en)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
US9598441B2
(en)
|
2011-08-30 |
2017-03-21 |
Wayne State University |
Therapeutic compounds and methods
|
CN103781471B
(zh)
|
2011-09-08 |
2019-02-12 |
健康科学西部大学 |
癌症治疗中的靶向脂质体
|
EP2755942A2
(en)
|
2011-09-15 |
2014-07-23 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
Therapeutic compounds
|
AU2012331702B2
(en)
*
|
2011-11-04 |
2017-10-26 |
Laurentia Holding B.V. |
Liposomal corticosteroids for treatment of inflammatory disorders in humans
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
WO2013103969A1
(en)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
US9512212B2
(en)
|
2012-01-11 |
2016-12-06 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
WO2013106756A2
(en)
|
2012-01-13 |
2013-07-18 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
WO2013110077A1
(en)
|
2012-01-19 |
2013-07-25 |
Hybrid Medical, Llc |
Topical therapeutic formulations
|
EP2804852A2
(en)
|
2012-01-20 |
2014-11-26 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
US9488664B2
(en)
|
2012-01-25 |
2016-11-08 |
Sbi Pharmaceuticals Co., Ltd. |
Diagnostic agent for tumor
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
US9897607B2
(en)
|
2012-02-01 |
2018-02-20 |
The Governors Of The University Of Alberta |
Methods, kits, and systems for treatment of metastatic papillary thyroid cancer
|
US9839634B2
(en)
|
2012-02-06 |
2017-12-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
US9688668B2
(en)
|
2012-02-08 |
2017-06-27 |
University Of Virginia Patent Foundation |
Long chain base sphingosine kinase inhibitors
|
CA2865983C
(en)
|
2012-03-02 |
2021-10-19 |
The Board Of Trustees Of The University Of Illinois |
Potent anticancer activity via dual compound activation
|
EP2822546B1
(en)
|
2012-03-06 |
2017-07-12 |
The Board of Trustees of the University of Illionis |
Procaspase combination therapy for treating cancer
|
WO2013142712A1
(en)
|
2012-03-21 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US9187446B2
(en)
|
2012-03-22 |
2015-11-17 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechainfluorinated myxopyronin derivatives
|
EP2831063B1
(en)
|
2012-03-26 |
2017-10-04 |
University of Iowa Research Foundation |
Schweinfurthin analogues
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
KR20150013232A
(ko)
|
2012-05-07 |
2015-02-04 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
골형성 및 헤지호그 신호전달을 유도하고 지방생성을 억제하는 옥시스테롤 유사체 oxy133
|
WO2013175386A1
(en)
|
2012-05-21 |
2013-11-28 |
Chemi Nutra Inc. |
Compositions and methods for increasing strength and muscle mass
|
US20130338114A1
(en)
|
2012-05-23 |
2013-12-19 |
Chemi Nutra |
Compositions for increasing strength, muscle mass, and lean body mass
|
WO2013181454A1
(en)
|
2012-05-30 |
2013-12-05 |
Biostrategies LC |
Plant lectins as carriers of associated drug substances into animal and human cells
|
EP2861558B1
(en)
|
2012-06-15 |
2017-01-18 |
Rutgers, The State University of New Jersey |
Macromolecules for treating atherosclerosis
|
SG11201408395WA
(en)
|
2012-06-18 |
2015-01-29 |
Dart Neuroscience Cayman Ltd |
Substituted pyridine azolopyrimidine - 5 - (6h) - one compounds
|
EP2861570B1
(en)
|
2012-06-19 |
2018-07-18 |
Rutgers, The State University of New Jersey |
Antibacterial agents: aryl myxopyronin derivatives
|
WO2013192388A1
(en)
|
2012-06-20 |
2013-12-27 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
CN104822695B
(zh)
|
2012-07-05 |
2018-01-09 |
衣阿华大学研究基金会 |
治疗性双膦酸盐
|
EP2872525B1
(en)
|
2012-07-10 |
2019-03-06 |
XPD Holdings LLC |
Stabilized multi-functional antioxidant compounds and methods of use
|
KR102178590B1
(ko)
|
2012-07-18 |
2020-11-13 |
유니버시티 오브 노트르 담 듀락 |
5,5-헤테로방향족 항-감염 화합물
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
WO2014018874A1
(en)
|
2012-07-26 |
2014-01-30 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
AU2013295584B2
(en)
|
2012-07-27 |
2018-03-15 |
Biogen Ma Inc. |
ATX modulating agents
|
US9067963B2
(en)
|
2012-08-01 |
2015-06-30 |
Lewis and Clark Pharmaceuticals, LLC |
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
|
RU2652989C2
(ru)
|
2012-08-03 |
2018-05-04 |
Зэ Борд оф Трастиз оф зэ Юниверсити оф Иллинойс |
Соединения и композиции, активирующие ферменты
|
ES2660287T3
(es)
|
2012-08-06 |
2018-03-21 |
Biogen Ma Inc. |
Compuestos que son agentes moduladores de s1p y/o agentes moduladores de atx
|
US9499485B2
(en)
|
2012-08-06 |
2016-11-22 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
WO2014028025A1
(en)
|
2012-08-16 |
2014-02-20 |
University Of Southern California |
Compositions and methods for treating myotonic dystrophy type 1
|
CN104736202B
(zh)
|
2012-08-22 |
2021-09-07 |
康奈尔大学 |
用于抑制肌成束蛋白的方法
|
WO2014039860A2
(en)
|
2012-09-07 |
2014-03-13 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating dnmt1 inhibitor activity
|
US9573938B2
(en)
|
2012-09-11 |
2017-02-21 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
TWI614029B
(zh)
|
2012-09-13 |
2018-02-11 |
長庚醫療財團法人 |
新穎醫藥組成物及其用途
|
WO2014041546A1
(en)
|
2012-09-13 |
2014-03-20 |
Ben-Gurion University Of The Negev Research And Development Authority |
Diagnostic agents with enhanced sensitivity/specificity
|
EA030128B1
(ru)
|
2012-09-26 |
2018-06-29 |
Арагон Фармасьютикалз, Инк. |
Способ лечения неметастатического кастрационно-резистентного рака простаты
|
EP2906260B1
(en)
|
2012-10-09 |
2019-06-26 |
Case Western Reserve University |
Rod-shaped plant virus nanoparticles as imaging agent platforms
|
WO2014059158A1
(en)
|
2012-10-10 |
2014-04-17 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For An On Behalf Of Arizona State University |
Multifunctional radical quenchers
|
US20140120057A1
(en)
|
2012-10-25 |
2014-05-01 |
Rutgers, The State University Of New Jersey |
Polymers and methods thereof for wound healing
|
WO2014066840A1
(en)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
WO2014070774A1
(en)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
CA2891092C
(en)
|
2012-11-08 |
2020-12-15 |
Taxis Pharmaceuticals, Inc. |
Antimicrobial agents
|
US9701638B2
(en)
|
2012-11-09 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
EP2919785A4
(en)
|
2012-11-16 |
2016-10-05 |
Biocryst Pharm Inc |
ANTIVIRAL NUCLEOSIDES CONTAINING AZASUCRE
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
ES2749467T3
(es)
|
2012-11-20 |
2020-03-20 |
Biogen Ma Inc |
Agentes moduladores de S1p y/o ATX
|
ES2636596T3
(es)
|
2012-11-20 |
2017-10-06 |
Biogen Ma Inc. |
Agentes moduladores de S1P y/o ATX
|
US9522131B2
(en)
|
2013-01-11 |
2016-12-20 |
Wisconsin Alumni Research Foundation |
Tannin-containing gastrointestinal formulations and methods of use
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
AU2014212465B2
(en)
|
2013-01-29 |
2018-07-12 |
Biogen Ma Inc. |
S1P modulating agents
|
US9981043B2
(en)
|
2013-02-08 |
2018-05-29 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
JP2016518240A
(ja)
|
2013-02-15 |
2016-06-23 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
粒子の官能化
|
EP2964618B1
(en)
|
2013-03-05 |
2019-09-04 |
University Of Notre Dame Du Lac |
Quinazolinone antibiotics
|
JP6346658B2
(ja)
|
2013-03-14 |
2018-06-20 |
ダート・ニューロサイエンス・(ケイマン)・リミテッド |
Mao阻害剤としての置換ナフチリジン及びキノリン化合物
|
RU2668073C2
(ru)
|
2013-03-14 |
2018-09-26 |
Дарт Нейросайенс (Кайман) Лтд. |
Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
WO2014143672A1
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
|
TW201446768A
(zh)
|
2013-03-15 |
2014-12-16 |
Biogen Idec Inc |
S1p及/或atx調節劑
|
CN107474034B
(zh)
|
2013-03-15 |
2020-06-30 |
瑞沙恩医药公司 |
用于制备碳环糖衍生物的方法
|
US20160024504A1
(en)
|
2013-03-15 |
2016-01-28 |
Constellation Pharmaceuticals, Inc. |
Treating th2-mediated diseases by inhibition of bromodomains
|
WO2014179756A1
(en)
|
2013-05-02 |
2014-11-06 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol-bone targeting agents
|
JP6208332B2
(ja)
|
2013-05-06 |
2017-10-04 |
カオシュン・チャン・グン・メモリアル・ホスピタル |
医薬組成物及びその用途
|
US9862672B2
(en)
|
2013-05-29 |
2018-01-09 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
EP3010507A4
(en)
|
2013-06-22 |
2017-06-07 |
Nitor Therapeutics |
Compositions and methods for potentiating immune response for the treatment of infectious diseases and cancer
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
CA2920100A1
(en)
|
2013-08-01 |
2015-02-05 |
Regents Of The University Of Minnesota |
Drug delivery method
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
WO2015021149A1
(en)
|
2013-08-06 |
2015-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
US10226534B2
(en)
|
2013-09-12 |
2019-03-12 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
US9878045B2
(en)
|
2013-10-15 |
2018-01-30 |
Regents Of The University Of Minnesota |
Triorthogonal reagents for dual protein conjugation
|
CN112353791A
(zh)
|
2013-11-11 |
2021-02-12 |
夸利蒂赫布丘蒂克斯公司 |
卡瓦衍生的治疗性化合物及其使用方法
|
US9387199B2
(en)
|
2013-11-12 |
2016-07-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating clostridium infection and preventing recurrence of infection
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
US10328040B2
(en)
|
2014-01-17 |
2019-06-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic methods
|
US9919998B2
(en)
|
2014-02-06 |
2018-03-20 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
|
WO2015123654A1
(en)
|
2014-02-17 |
2015-08-20 |
The Cleveland Clinic Foundation |
Amine passivated nanoparticles for cancer treatment and imaging
|
EP3107902B1
(en)
|
2014-02-20 |
2021-04-07 |
Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") |
Compounds and methods for inhibiting fascin
|
WO2015130805A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dna gridiron compositions and methods
|
WO2015130973A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
EP4180424A1
(en)
|
2014-03-07 |
2023-05-17 |
BioCryst Pharmaceuticals, Inc. |
Substituted pyrazoles as human plasma kallikrein inhibitors
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
CA2946112C
(en)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
PL3597649T3
(pl)
|
2014-04-23 |
2022-04-04 |
Dart Neuroscience Llc |
Kompozycje zawierające podstawione związki [1,2,4]triazolo[1,5-a]pirymidyn-7-ylowe jako inhibitory pde2
|
MA39888A
(fr)
|
2014-04-24 |
2017-03-01 |
Dart Neuroscience Cayman Ltd |
Composés de 2,4,5,6-tétrahydropyrrolo[3,4-c] pyrazole et 4,5,6,7-tétrahydro-2 h-pyrazolo [4,3-c] pyridine utilisés comme inhibiteurs de glyt1
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
WO2015188051A1
(en)
|
2014-06-06 |
2015-12-10 |
Biogen Ma Inc. |
Atx modulating agents
|
WO2015191742A1
(en)
|
2014-06-13 |
2015-12-17 |
Rutgers, The State University Of New Jersey |
Process and intermediates for preparing poly(anhydride-esters)
|
US10138203B2
(en)
|
2014-06-16 |
2018-11-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
WO2016007909A2
(en)
|
2014-07-11 |
2016-01-14 |
Biostrategies LC |
Materials and methods for treating disorders associated with sulfatase enzymes
|
TW201613872A
(en)
|
2014-07-18 |
2016-04-16 |
Biogen Ma Inc |
IRAK4 inhibiting agents
|
BR112017002807A2
(pt)
*
|
2014-08-19 |
2017-12-19 |
Nat Univ Corporation Okayama Univ |
método para aprimorar a função de célula imune e método para avaliar a mulfuncionalidade de célula imune
|
CA2957691C
(en)
|
2014-08-19 |
2023-10-31 |
Marvin J. Miller |
Antibacterial sideromycins
|
US10385034B2
(en)
|
2014-09-05 |
2019-08-20 |
The Cleveland Clinic Foundation |
Flavonoid IL-17A inhibitors
|
US9630905B2
(en)
|
2014-09-08 |
2017-04-25 |
Rutgers, The State University Of New Jersey |
Amphiphilic macromolecules and methods of use thereof
|
PT3191086T
(pt)
|
2014-09-11 |
2021-08-03 |
Univ Iowa Res Found |
Timol e carvacol para utilização em medicina
|
US10328114B2
(en)
|
2014-10-28 |
2019-06-25 |
University Of Iowa Research Foundation |
Lung injury repair compositions and methods
|
EP3215508A1
(en)
|
2014-11-05 |
2017-09-13 |
Dart NeuroScience (Cayman) Ltd. |
Substituted 5-methyl-[1, 2, 4]triazolo [1,5-a) pyrimidin-2-amine compounds as pde2 inhibitors
|
WO2016073420A1
(en)
|
2014-11-05 |
2016-05-12 |
Dart Neuroscience, Llc |
Substituted azetidinyl compounds as glyt1 inhibitors
|
SG11201703810QA
(en)
*
|
2014-11-10 |
2017-06-29 |
Del Mar Pharmaceuticals |
Dianhydrogalactitol together with radiation to treat non-small-cell carcinoma of the lung and glioblastoma multiforme
|
US10920195B2
(en)
|
2014-11-13 |
2021-02-16 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
US9925269B2
(en)
|
2014-11-17 |
2018-03-27 |
Cellectar Biosciences, Inc. |
Phospholipid ether analogs as cancer-targeting drug vehicles
|
PT3233910T
(pt)
|
2014-12-19 |
2020-03-17 |
Ablynx Nv |
Dímeros de nanocorpos ligados a cisteína
|
EP3250223A1
(en)
|
2015-01-08 |
2017-12-06 |
University of Iowa Research Foundation |
Methods for the regeneration of articular cartilage in vivo
|
WO2016115516A1
(en)
|
2015-01-16 |
2016-07-21 |
University Of Iowa Research Foundation |
Methods to prevent or treat periodontitis or peri-implantitis
|
WO2016133995A1
(en)
|
2015-02-17 |
2016-08-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Phenothiazine analogues as mitochondrial therapeutic agents
|
EP3259254B1
(en)
|
2015-02-17 |
2020-07-01 |
Arizona Board of Regents on behalf of Arizona State University |
Deuterated and undeuterated 2-amino-pyrimidin-5-ol derivatives for treating mitochondrial diseases (e.g. obesity)
|
US10221143B2
(en)
|
2015-03-03 |
2019-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted anilines for treatment of animal diseases
|
WO2016140979A1
(en)
|
2015-03-03 |
2016-09-09 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
MX2017011237A
(es)
|
2015-03-06 |
2017-11-28 |
Cleveland Clinic Found |
Alteracion del metabolismo de esteroides para el tratamiento de enfermedades dependientes de esteroides.
|
US9926261B2
(en)
|
2015-03-10 |
2018-03-27 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
US9950993B2
(en)
|
2015-03-13 |
2018-04-24 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JP6930918B6
(ja)
|
2015-04-10 |
2021-12-15 |
ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー |
コウジ酸ポリマー
|
AU2016258123A1
(en)
|
2015-05-06 |
2018-01-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target MC1R
|
CN108026084A
(zh)
|
2015-05-07 |
2018-05-11 |
夸利蒂赫布丘蒂克斯公司 |
治疗化合物及其使用方法
|
WO2016187100A1
(en)
|
2015-05-15 |
2016-11-24 |
The Methodist Hospital System |
Implantable nanochannel delivery devices
|
EP3297655B1
(en)
|
2015-05-18 |
2020-04-15 |
Arizona Board of Regents on Behalf of the University of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
CN117257802A
(zh)
|
2015-06-05 |
2023-12-22 |
伊利诺伊大学董事会 |
Pac-1联合疗法
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
WO2016205397A2
(en)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Target-specific delivery of therapeutic agents
|
WO2016205534A1
(en)
|
2015-06-16 |
2016-12-22 |
Lazo John S |
Inhibitors of ptp4a3 for the treatment of cancer
|
US9399039B1
(en)
|
2015-06-30 |
2016-07-26 |
University Of South Florida |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
|
US10814006B2
(en)
|
2015-07-14 |
2020-10-27 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
WO2017011826A1
(en)
|
2015-07-16 |
2017-01-19 |
Case Western Reserve University |
Plant virus particles for delivery of antimitotic agents
|
US10729669B2
(en)
|
2015-07-28 |
2020-08-04 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
AU2016301212A1
(en)
|
2015-08-02 |
2018-03-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
US10550124B2
(en)
|
2015-08-13 |
2020-02-04 |
San Diego State University Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
WO2017040778A1
(en)
|
2015-09-04 |
2017-03-09 |
Janssen Pharmaceutica Nv |
Therapeutic compound for pain and synthesis thereof
|
TWI734702B
(zh)
|
2015-10-01 |
2021-08-01 |
美商百歐克斯製藥公司 |
人類血漿激肽釋放酶抑制劑
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
EP3365018A1
(en)
|
2015-10-20 |
2018-08-29 |
The Cleveland Clinic Foundation |
Stimulation of 11beta -hsd2 expression to improve hormonal therapy of steroid-dependent disease
|
WO2017079335A1
(en)
|
2015-11-03 |
2017-05-11 |
Regents Of The University Of Minnesota |
Cd200 inhibitors and methods of use thereof
|
AU2016355268B2
(en)
|
2015-11-20 |
2021-08-19 |
Senhwa Biosciences, Inc. |
Combination therapy of tetracyclic quinolone analogs for treating cancer
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
ES2904557T3
(es)
|
2016-01-20 |
2022-04-05 |
Biogen Ma Inc |
Agentes inhibidores de irak4
|
TW202222786A
(zh)
|
2016-02-01 |
2022-06-16 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
US11203576B2
(en)
|
2016-03-11 |
2021-12-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and Janus kinase inhibitors for prevention of graft versus host disease
|
US11395820B2
(en)
|
2016-03-16 |
2022-07-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecules against cereblon to enhance effector t cell function
|
CA3018750A1
(en)
|
2016-03-22 |
2017-09-28 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
EP3442979A4
(en)
|
2016-04-04 |
2019-12-18 |
Rutgers, the State University of New Jersey |
topoisomerase poisons
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
PT3445838T
(pt)
|
2016-04-18 |
2023-06-16 |
Gene Pool Tech Inc |
Isolamento de extratos vegetais
|
WO2017192798A1
(en)
|
2016-05-04 |
2017-11-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
EP3463574B1
(en)
|
2016-05-26 |
2021-11-03 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Compositions and methods for treating pulmonary vascular disease
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
US11351270B2
(en)
|
2016-06-07 |
2022-06-07 |
University Of Iowa Research Foundation |
Junctophilin-2 fragments and uses therefor
|
CN110337293A
(zh)
|
2016-06-20 |
2019-10-15 |
新泽西鲁特格斯州立大学 |
治疗性化合物
|
AU2017281940A1
(en)
|
2016-06-24 |
2019-01-24 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
EP3490552B1
(en)
|
2016-07-26 |
2022-11-23 |
University of Southern California |
Selective bromodomain inhibition of fungal bdf1
|
US20180037909A1
(en)
|
2016-08-04 |
2018-02-08 |
Chang Gung Memorial Hospital, Linkou |
Modified cancer cell lines and uses thereof
|
WO2018039077A1
(en)
|
2016-08-25 |
2018-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
WO2018044896A1
(en)
|
2016-08-31 |
2018-03-08 |
Dart Neuroscience, Llc |
Hydroxynorketamine derivatives for the treatment of cns disorders
|
CA3039853A1
(en)
|
2016-10-17 |
2018-04-26 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
ES2942285T3
(es)
|
2016-10-31 |
2023-05-31 |
Biocryst Pharm Inc |
Profármacos de inhibidores de la calicreína
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
JP7136795B2
(ja)
|
2016-11-29 |
2022-09-13 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
母体の健康および/または子の健康を向上させるためのnad前駆体の使用
|
US20180194824A1
(en)
|
2016-12-14 |
2018-07-12 |
University Of Iowa Research Foundation |
Musclin peptides and methods of use thereof
|
AR110590A1
(es)
|
2016-12-27 |
2019-04-10 |
Biogen Ma Inc |
Activador de nrf2
|
JP7111720B2
(ja)
|
2016-12-28 |
2022-08-02 |
ダート・ニューロサイエンス・エルエルシー |
Pde2阻害剤としての置換ピラゾロピリミジノン化合物
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
EP3571183B1
(en)
|
2017-01-20 |
2024-03-06 |
The Regents of the University of California |
3-(phenyl)-2-(aminomethyl)-1-phenyl-2-propen-1-one derivatives as inhibitors of the n-terminal domain of the androgen receptor for treating prostate cancer
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
US11090289B2
(en)
|
2017-01-24 |
2021-08-17 |
University Of Virginia Patent Foundation |
Compositions and methods for blocking sodium channels
|
WO2018140738A1
(en)
|
2017-01-30 |
2018-08-02 |
Biogen Ma Inc. |
Nrf 2 activator
|
US20190389836A1
(en)
|
2017-01-30 |
2019-12-26 |
Biogen Ma Inc. |
Nrf2 activator
|
US11168095B2
(en)
|
2017-02-07 |
2021-11-09 |
Biogen Ma Inc. |
ASK1 inhibiting agents
|
WO2018150276A2
(en)
|
2017-02-16 |
2018-08-23 |
Universidad San Sebastian |
The combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological conditions
|
US11180459B2
(en)
|
2017-03-10 |
2021-11-23 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
SG11201908351TA
(en)
|
2017-03-10 |
2019-10-30 |
Edmond J Lavoie |
Indole derivatives as efflux pump inhibitors
|
WO2018165614A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
CA3063174A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
WO2018217757A1
(en)
|
2017-05-22 |
2018-11-29 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
JP7281822B2
(ja)
|
2017-05-26 |
2023-05-26 |
ラトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー |
細菌の排出ポンプ阻害剤
|
TWI826376B
(zh)
|
2017-06-02 |
2023-12-21 |
德商麥克專利有限公司 |
與adamts5、mmp13及聚集蛋白聚醣結合的多肽
|
EP3630847A1
(en)
|
2017-06-02 |
2020-04-08 |
Merck Patent GmbH |
Adamts binding immunoglobulins
|
AU2018277310A1
(en)
|
2017-06-02 |
2019-12-12 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
US20200190216A1
(en)
|
2017-06-02 |
2020-06-18 |
Merck Patent Gmbh |
Mmp13 binding immunoglobulins
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
EP3641783A4
(en)
|
2017-06-22 |
2021-03-10 |
University Of Virginia Patent Foundation |
PROTON-ACTIVATED NUCLEAR MEDICINE
|
WO2018237134A1
(en)
|
2017-06-23 |
2018-12-27 |
San Diego State University Research Foundation |
ATROPISOMERISM FOR ENHANCED SELECTIVITY OF KINASE INHIBITORS
|
WO2019005841A1
(en)
|
2017-06-26 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
|
WO2019014305A1
(en)
|
2017-07-12 |
2019-01-17 |
Dart Neuroscience, Llc |
SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS
|
CN107446050A
(zh)
|
2017-08-11 |
2017-12-08 |
百奥泰生物科技(广州)有限公司 |
Trop2阳性疾病治疗的化合物及方法
|
WO2019046467A1
(en)
|
2017-08-29 |
2019-03-07 |
Rutgers, The State University Of New Jersey |
INDAZOLES THERAPEUTIC
|
US11254941B2
(en)
|
2017-08-30 |
2022-02-22 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA nanostructures and methods of making and using RNA nanostructures
|
CN111757738A
(zh)
|
2017-10-06 |
2020-10-09 |
蓝色治疗公司 |
治疗急性或慢性疼痛的方法
|
US10702508B2
(en)
|
2017-10-16 |
2020-07-07 |
Aragon Pharmaceuticals, Inc. |
Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
|
WO2019079384A1
(en)
|
2017-10-17 |
2019-04-25 |
The Methodist Hospital System |
ADMINISTRATION DEVICES
|
WO2019104030A1
(en)
|
2017-11-21 |
2019-05-31 |
Biogen Ma Inc. |
Tetrahydronaphthalene derivatives useful as nrf2 activators
|
CA3120971A1
(en)
|
2017-11-27 |
2019-05-31 |
Dart Neuroscience, Llc |
Substituted furanopyrimidine compounds as pde1 inhibitors
|
EP3716956A1
(en)
|
2017-11-29 |
2020-10-07 |
The Cleveland Clinic Foundation |
Antitumor tet2 modulating compounds
|
ES2969958T3
(es)
|
2017-11-30 |
2024-05-23 |
Cytogel Pharma Llc |
Formulaciones farmacéuticas analgésicas novedosas y usos de las mismas
|
WO2019112885A1
(en)
|
2017-12-07 |
2019-06-13 |
The Cleveland Clinic Foundation |
Treatment of steroid-resistant disease using an anthocyanin and a corticosteroid
|
WO2019140140A1
(en)
|
2018-01-10 |
2019-07-18 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna-nanostructured double robots and methods of use thereof
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
US11685723B2
(en)
|
2018-02-13 |
2023-06-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: O-alkyl-deuterated pyronins
|
JP7445597B2
(ja)
|
2018-02-15 |
2024-03-07 |
センワ バイオサイエンシズ インコーポレイテッド |
キノロン類似体及びそれらの塩、組成物、ならびにそれらの使用方法
|
WO2019168921A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/parp inhibitor in the treatment of cancer
|
US11365191B2
(en)
|
2018-02-28 |
2022-06-21 |
Dart Neuroscience, Llc |
Substituted cyclohexyl compounds as NOP inhibiiors
|
US11572337B2
(en)
|
2018-03-06 |
2023-02-07 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: arylalkylcarboxamido phloroglucinols
|
US20210255170A1
(en)
|
2018-03-13 |
2021-08-19 |
University Of Iowa Research Foundation |
Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
|
EP4186899A1
(en)
|
2018-03-14 |
2023-05-31 |
Biogen MA Inc. |
O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
CN112261941A
(zh)
|
2018-04-20 |
2021-01-22 |
弗吉尼亚理工大学知识产权有限公司 |
可用作线粒体解偶联剂的氨基吡嗪及相关化合物
|
WO2020036654A2
(en)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
US10899753B2
(en)
|
2018-05-14 |
2021-01-26 |
Biogen Ma Inc. |
Inhibiting agents for Bruton's tyrosine kinase
|
AU2019291806A1
(en)
|
2018-06-27 |
2021-01-07 |
Biogen Ma Inc. |
Ask1 inhibiting agents
|
WO2020014118A1
(en)
|
2018-07-09 |
2020-01-16 |
Taiwan Liposome Co., Ltd. |
Methods to reduce complications of intra-articular steroid
|
WO2020014489A2
(en)
|
2018-07-11 |
2020-01-16 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
US11987568B2
(en)
|
2018-08-03 |
2024-05-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of WEE1 kinase
|
US11897898B2
(en)
|
2018-08-14 |
2024-02-13 |
Biogen Ma Inc. |
Pyridine macrocycle compounds as ASK1 inhibiting agents
|
BR112021002690A2
(pt)
|
2018-08-14 |
2021-05-11 |
Biogen Ma Inc. |
agentes inibidores de ask1
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
KR20210058880A
(ko)
|
2018-09-13 |
2021-05-24 |
미네암리타 테라퓨틱스, 엘엘씨 |
섬유증, nash, 및 nafld를 치료하기 위한 방법에서 사용을 위한 트립톨리드 및 이의 전구약물
|
MX2021003232A
(es)
|
2018-09-19 |
2021-07-16 |
Biogen Ma Inc |
Inhibidores de o-glicoproteina-2-acetamido-2-desoxi-3-d-glucopiran osidasa.
|
WO2020081514A1
(en)
|
2018-10-15 |
2020-04-23 |
Biogen Ma Inc. |
Crystalline polymorphs of bruton's tyrosine kinase inhibitors
|
EP3866834A1
(en)
|
2018-10-17 |
2021-08-25 |
Sunstate Biosciences, LLC |
Single protein-encapsulated pharmaceutics for enhancing therapeutic effects
|
EP3876827B1
(en)
|
2018-11-09 |
2023-09-27 |
The University of Rochester |
Methods detrmining a treatment for cancer based on response prediction using light scattering technology
|
CN113302206A
(zh)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
治疗脂质代谢失调的方法
|
TW202039482A
(zh)
|
2018-12-05 |
2020-11-01 |
美商百健Ma公司 |
嗎啉基、哌嗪基、氧氮雜環庚烷基及二氮雜環庚烷基o-醣蛋白-2-乙醯胺基-2-去氧-3-d-葡萄哌喃醣苷酶抑制劑
|
AU2020208192A1
(en)
|
2019-01-14 |
2021-08-05 |
Regents Of The University Of Minnesota |
CD200AR ligands for cancer immunotherapy
|
AR117989A1
(es)
|
2019-02-04 |
2021-09-08 |
Biogen Ma Inc |
Inhibidores de o-glucoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa de éter bicíclico
|
WO2020185593A1
(en)
|
2019-03-08 |
2020-09-17 |
Biogen Ma Inc. |
Azetidinyl 0-glyc0pr0tein-2-acetamid0-2-deoxy-3-d-gluc0pyran0sidase inhibitors
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
WO2020232330A1
(en)
|
2019-05-15 |
2020-11-19 |
Biogen Ma Inc. |
Inhibiting agents for bruton's tyrosine kinase
|
US20220241214A1
(en)
|
2019-06-20 |
2022-08-04 |
University Of Iowa Research Foundation |
Nanoparticles comprising quinone w methides and compositions for use
|
US20220411398A1
(en)
|
2019-06-24 |
2022-12-29 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
PE20221009A1
(es)
|
2019-08-06 |
2022-06-15 |
Biocryst Pharm Inc |
Sintesis de un inhibidor de calicreina plasmatica a escala de proceso
|
CN115279756A
(zh)
|
2019-10-25 |
2022-11-01 |
埃克森特治疗公司 |
Mettl3调节剂
|
AR120324A1
(es)
|
2019-10-29 |
2022-02-09 |
Biogen Ma Inc |
Inhibidores de o-glucoproteína-2-acetamido-2-deoxi-3-d-glucopiranosidasa espirocíclica
|
US20220411429A1
(en)
|
2019-10-30 |
2022-12-29 |
Biogen Ma Inc. |
Condensed pyridazine or pyrimidine as btk inhibitors
|
EP4051680A1
(en)
|
2019-10-30 |
2022-09-07 |
Biogen MA Inc. |
Condensed bi-heterocycles as inhibiting agents for bruton's tyrosine kinase
|
EP4081514A1
(en)
|
2019-12-23 |
2022-11-02 |
Biogen MA Inc. |
Btk inhibitors
|
WO2021142230A1
(en)
|
2020-01-10 |
2021-07-15 |
Cornell University |
Methods to alter latency in ebv+ malignancies
|
EP4153578A1
(en)
|
2020-05-18 |
2023-03-29 |
Salk Institute for Biological Studies |
Chromen-4-one derivatives, such as e.g. flavones, for use as ck2 inhibitors for the treatment of neuroinflammation
|
TWI776584B
(zh)
|
2020-07-10 |
2022-09-01 |
長庚醫療財團法人林口長庚紀念醫院 |
β-1腎上腺素受體拮抗劑用於製備減少表皮生長因子受體抑制劑誘導的上皮細胞損傷以及抑制癌細胞的組合物之用途
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
TW202220972A
(zh)
|
2020-08-07 |
2022-06-01 |
美商百健Ma公司 |
Btk抑制劑
|
EP4208455A1
(en)
|
2020-09-02 |
2023-07-12 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Lzk-targeting degraders and methods of use
|
JP2023546549A
(ja)
|
2020-10-14 |
2023-11-02 |
アクセント・セラピューティクス・インコーポレイテッド |
Mettl3モジュレーター
|
EP4274832A1
(en)
|
2021-01-07 |
2023-11-15 |
Biogen MA Inc. |
Tyk2 inhibitors
|
IL305029A
(en)
|
2021-02-22 |
2023-10-01 |
Univ Minnesota |
Immune modulators and conjugates of immune modulators
|
TWI796023B
(zh)
|
2021-03-10 |
2023-03-11 |
長庚醫療財團法人 |
藥物組合物及其用途
|
EP4313023A1
(en)
|
2021-04-02 |
2024-02-07 |
Biogen MA Inc. |
Combination treatment methods of multiple sclerosis
|
JP2024516023A
(ja)
|
2021-05-04 |
2024-04-11 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
避妊薬の化合物及び方法
|
CN117580592A
(zh)
|
2021-05-05 |
2024-02-20 |
渤健马萨诸塞州股份有限公司 |
用于靶向布鲁顿酪氨酸激酶降解的化合物
|
AU2022297453A1
(en)
|
2021-06-22 |
2024-01-04 |
Crimson Biopharm Inc. |
(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of egfr for use in the treatment of brain tumors
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
UY39844A
(es)
|
2021-07-07 |
2023-01-31 |
Biogen Ma Inc |
Compuestos para la degradación selectiva de las proteínas irak4
|
EP4366834A1
(en)
|
2021-07-07 |
2024-05-15 |
Biogen MA Inc. |
Compounds for targeting degradation of irak4 proteins
|
AU2022340743A1
(en)
|
2021-09-01 |
2024-03-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mixed lineage kinase inhibitors and methods of use
|
WO2023081237A1
(en)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
WO2023086521A1
(en)
|
2021-11-10 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
WO2023086575A1
(en)
|
2021-11-12 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
WO2023092060A1
(en)
|
2021-11-18 |
2023-05-25 |
Cornell University |
Microrna-dependent mrna switches for tissue-specific mrna-based therapies
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
WO2023220049A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
|
WO2023220046A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
WO2024006493A1
(en)
|
2022-07-01 |
2024-01-04 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
WO2024011214A1
(en)
|
2022-07-08 |
2024-01-11 |
Actio Biosciences, Inc. |
Therapeutic compounds and methods
|
WO2024100093A1
(en)
|
2022-11-09 |
2024-05-16 |
Merck Patent Gmbh |
Toll-like receptor 7 agonists as immune-stimulators to elicit the innate antitumor immunity
|